Skip to main content
APhA 2024 Annual Meeting and Exposition Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 2

Satellite Symposia

Satellite Symposium: Optimizing Care for Chronic Worsening Heart Failure

Saturday, March 23, 2024
6:30 AM – 8:00 AM East Coast USA Time
Location: Hyatt Regency, Orlando Ballroom M
CE: 1.5

Number of Hours: 1.5

Activity Type: Knowledge-based

Breakfast: 6:00 AM - 6:30 AM ET

This activity will explore the recently updated heart failure with reduced ejection fraction (HFrEF) management guidelines and novel treatments available. Patient counseling video vignettes will be used to emphasize key considerations for pharmacists when optimizing management of patients with HFrEF.
This activity includes patient counseling vignettes.

This activity is supported by an educational grant from Merck & Co, Inc, Rahway, NJ, USA.

Registration is now open.

Click here to register

Learning Objectives:

  • Examine the clinical and economic burden of chronic worsening heart failure with reduced ejection fraction (HFrEF) and the risk for recurrent cardiovascular events
  • Analyze the key updates and recommendations in the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America guidelines relevant to the management of worsening HFrEF
  • Investigate the role of soluble guanylate cyclase stimulators and supporting clinical data for the management of chronic worsening HFrEF
  • Identify the various components of the pharmacist’s role in personalized management of worsening HFrEF, encompassing medication therapy management, patient education, adherence support, adverse effect monitoring, and interdisciplinary collaboration